Bae, Eun-Jin
Pérez-Acuña, Dayana
Rhee, Ka Hyun
Lee, Seung-Jae
Funding for this research was provided by:
Ministry of Science and ICT, South Korea (NRF-2018R1A5A2025964)
Article History
Received: 12 July 2023
Accepted: 6 September 2023
First Online: 14 September 2023
Declarations
:
: All mouse studies were conducted in compliance with the relevant ethics regulations and approved by the Seoul National University Ethics Committee (SNU-190417–2-6).
: Not applicable.
: S-JL is a co-founder and CEO of Neuramedy Co. Ltd.